The Trans-Pacific Partnership (TPP) is currently being negotiated
among 12 Pacific Rim countries: Australia, Brunei, Canada,
Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore,
the United States, and Vietnam. If passed, it will become the
largest U.S. free trade agreement (FTA) in history. It is anticipated
that the agreement will expand existing intellectual property (IP)
protections on pharmaceutical products, which will ultimately
impede access to affordable generic medicines for diseases
such as HIV/AIDS, cancer, tuberculosis, and hepatitis C.
Download the full brief here.